Market Definition:
• The drugs that act on the nervous system to relieve pain are known as Opioids. They are also sometimes known as narcotics and are the medicines which are prescribed by the doctors to treat severe constant pain for the patients who suffer from terminal diseases.
• Opioids are used as cough suppressant, anaesthesia, and diarrhoea suppressant to reduce surgical pain, injury or trauma, cancer pain and pain arising from various other illness.
• Opioids are used by people dealing with chronic headaches and backaches and by patients who are recovering from surgery or experiencing severe pain associated with cancer.
Market Overview and Trends
• The rising frequency of disease conditions with severe pain, such as lower back pain, cancer, fibromyalgia and arthritis are driving the opioids market.
• The market is projected to be driven by the growing geriatric population, along with increasing focus on palliative care.
• Due to the considerable number of drug-abuse deaths registered in the country the market is being strictly regulated by the U.S. FDA. The FDA has discovered certain guidelines to manufacture, store, market and sell opioid products.
• The U.S. FDA discontinued the most widely prescribed opioids, Vicodin (Hydrocodone) and Percocet (Oxycodone), from the market.
Market Dynamics:
Factors Influencing the Market Growth:
• Considerable rise in road accidents and trauma, along with repeatedly increasing cases of surgical procedures, are driving the demand for opioid-based pain management solutions.
• The global opioids market is expected to increase its growth by the rise in disposable income and surge in the global geriatric population.
• The market is observing high growth due to increasing prevalence of chronic pain and orthopaedic diseases, rising focus on abuse-deterrent formulation (ADF), rising palliative care facilities, etc.
Factors Restraining the Market Growth:
• Factors such as prescription drug abuse, and legalisation of cannabis as an alternative to opioids may hamper the growth of the market in the coming years.
Market Segmentation 2019-2029:
The Global Opioids Market is segmented on the Product, Application and Region.
1. Global Opioids Market, by Product
a) Codeine
b) Fentanyl
c) Meperidine
d) Methadone
e) Morphine
f) Hydrocodone
2. Global Opioids market, by Application
a) Pain Management
– Neuropathic Pain
– Migraine
– Back Pain
– Osteoarthritis Pain
– Cancer Pain
– Others
b) Cold and Cough
c) Diarrhoea
d) Other Applications
3. Global Opioids market, by Region
a) North America
– US
– Canada
b) Europe
– Germany
– UK
– France
– Rest of Europe
c) Asia Pacific
– Japan
– China
– India
– Rest of Asia Pacific
d) Rest of the World (RoW)
Competitive Analysis:
• Research and development is the primary strategy adopted by the key players in the Global Biodefense market.
• These companies have developed various strategies and developments such as product launch, partnerships, mergers & acquisitions, joint venture, and collaborations.
Major Market Players:
Pfizer Inc., Purdue Pharma, Boehringer Ingelheim, Janssen Pharmaceuticals, Inc., Actavis Plc., Sanofi, Sun Pharmaceutical Industries Ltd., Mallinckrodt Pharmaceuticals, Endo Pharmaceuticals Inc. and Egalet.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
1. Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Stakeholders
2. Research Methodology
2.1 Research Data
2.1.1 Primary Data
2.1.2 Secondary Data
2.2 Market Size Estimation
2.3 Research Assumptions
3. Executive Summary
4. Industry Insights
5. Global Opioids market – By Product
5.1 Codeine
5.2 Fentanyl
5.3 Meperidine
5.4 Methadone
5.5 Morphine
5.6 Hydrocodone
6. Global Opioids market – By Application
6.1 Pain Management
6.1.1 Neuropathic Pain
6.1.2 Migraine
6.1.3 Back Pain
6.1.4 Osteoarthritis Pain
6.1.5 Cancer Pain
6.1.6 Others
6.2 Cough Treatment
6.3 Diarrhoea Treatment
7. Global Opioids market – By Region
7.1 North America
7.1.1 US
7.1.2 Canada
7.2 Europe
7.2.1 Germany
7.2.2 France
7.2.3 UK
7.2.4 Rest of Europe
7.3 Asia-Pacific
7.3.1 Japan
7.3.2 China
7.3.3 India
7.3.4 Rest of APAC
7.4 LAMEA
7.4.1 Latin America
7.4.2 Middle East
7.4.3 Africa
8. Competitive Landscape
9. Company Profiles
9.1 Pfizer Inc.
9.2 Purdue Pharma
9.3 Boehringer Ingelheim
9.4 Janssen Pharmaceuticals, Inc.
9.5 Actavis Plc.
9.6 Sanofi
9.7 Sun Pharmaceutical Industries Ltd.
9.8 Mallinckrodt Pharmaceuticals
9.9 Endo Pharmaceuticals Inc.
9.10 Egalet.
9.11 Other Players
10. Appendix
List of Tables
Table 1 Global Opioids Market Revenue Analysis & Forecast, By Product, (US$ Mn AGR%, CAGR %), 2019-2029
Table 2 Global Opioids Market Revenue Analysis & Forecast, By Application, (US$ Mn AGR%, CAGR %), 2019-2029
Table 4 Global Opioids Market Revenue Analysis & Forecast, By Region, (US$ Mn AGR%, CAGR %), 2019-2029
Table 5 North America Global Opioids Market Revenue Analysis & Forecast, By Product, (US$ Mn AGR%, CAGR %), 2019-2029
Table 7 North America Global Opioids Market Revenue Analysis & Forecast, By Application, (US$ Mn AGR%, CAGR %), 2019-2029
Table 9 U.S. Global Opioids Market Revenue Analysis & Forecast, By Product, (US$ Mn AGR%, CAGR%), 2019-2029
Table 10 U.S. Global Opioids Market Revenue Analysis & Forecast, By Application, (US$ Mn AGR%, CAGR %), 2019-2029
Table 12 Canada Global Opioids Market Revenue Analysis & Forecast, By Product, (US$ Mn AGR%, CAGR%), 2019-2029
Table 14 Canada Global Opioids Market Revenue Analysis & Forecast, By Application, (US$ Mn AGR%, CAGR %), 2019-2029
Table 16 Europe Global Opioids Market Revenue Analysis & Forecast, By Product, (US$ Mn AGR%, CAGR%), 2019-2029
Table 17 Europe Global Opioids Market Revenue Analysis & Forecast, By Application, (US$ Mn AGR%, CAGR %), 2019-2029
Table 19 Germany Global Opioids Market Revenue Analysis & Forecast, By Product, (US$ Mn AGR%, CAGR%), 2019-2029
Table 20 Germany Global Opioids Market Revenue Analysis & Forecast, By Application, (US$ Mn AGR%, CAGR %), 2019-2029
Table 22 France Global Opioids Market Revenue Analysis & Forecast, By Product, (US$ Mn AGR%, CAGR%), 2019-2029
Table 23 France Global Opioids Market Revenue Analysis & Forecast, By Application, (US$ Mn AGR%, CAGR %), 2019-2029
Table 24 UK Global Opioids Market Revenue Analysis & Forecast, By Product, (US$ Mn AGR%, CAGR%), 2019-2029
Table 25 UK Global Opioids Market Revenue Analysis & Forecast, By Application, (US$ Mn AGR%, CAGR %), 2019-2029
Table 27 Rest of Europe Global Opioids Market Revenue Analysis & Forecast, By Product, (US$ Mn AGR%, CAGR %), 2019-2029
Table 29 Rest of Europe Global Opioids Market Revenue Analysis & Forecast, By Application, (US$ Mn AGR%, CAGR %), 2019-2029
Table 30 Asia-Pacific Global Opioids Market Revenue Analysis & Forecast, By Product, (US$ Mn AGR%, CAGR %), 2019-2029
Table 32 Asia-Pacific Global Opioids Market Revenue Analysis & Forecast, By Application, (US$ Mn AGR%, CAGR %), 2019-2029
Table 33 Japan Global Opioids Market Revenue Analysis & Forecast, By Product, (US$ Mn AGR%, CAGR %), 2019-2029
Table 35 Japan Global Opioids Market Revenue Analysis & Forecast, By Application, (US$ Mn AGR%, CAGR %), 2019-2029
Table 37 China Global Opioids Market Revenue Analysis & Forecast, By Product, (US$ Mn AGR%, CAGR %), 2019-2029
Table 39 China Global Opioids Market Revenue Analysis & Forecast, By Application, (US$ Mn AGR%, CAGR %), 2019-2029
Table 41 India Global Opioids Market Revenue Analysis & Forecast, By Product, (US$ Mn AGR%, CAGR %), 2019-2029
Table 42 India Global Opioids Market Revenue Analysis & Forecast, By Application, (US$ Mn AGR%, CAGR %), 2019-2029
Table 44 Rest of APAC Global Opioids Market Revenue Analysis & Forecast, By Product, (US$ Mn AGR%, CAGR %), 2019-2029
Table 45 Rest of APAC Global Opioids Market Revenue Analysis & Forecast, By Application, (US$ Mn AGR%, CAGR %), 2019-2029
Table 47 LAMEA Global Opioids Market Revenue Analysis & Forecast, By Product, (US$ Mn AGR%, CAGR %), 2019-2029
Table 48 LAMEA Global Opioids Market Revenue Analysis & Forecast, By Application, (US$ Mn AGR%, CAGR %), 2019-2029
Table 49 Latin America Global Opioids Market Revenue Analysis & Forecast, By Product, (US$ Mn AGR%, CAGR %), 2019-2029
Table 50 Latin America Global Opioids Market Revenue Analysis & Forecast, By Application, (US$ Mn AGR%, CAGR %), 2019-2029
Table 52 Middle East Global Opioids Market Revenue Analysis & Forecast, By Product, (US$ Mn AGR%, CAGR %), 2019-2029
Table 53 Middle East Global Opioids Market Revenue Analysis & Forecast, By Application, (US$ Mn AGR%, CAGR %), 2019-2029
Table 56 Africa Global Opioids Market Revenue Analysis & Forecast, By Product, (US$ Mn AGR%, CAGR %), 2019-2029
Table 57 Africa Global Opioids Market Revenue Analysis & Forecast, By Application, (US$ Mn AGR%, CAGR %), 2019-2029
List of Figures
Figure 1 Global Clinical laboratory Service Market: Segmentation
Figure 2 Global Clinical laboratory Service Market: Research Design
Figure 3 Global Clinical laboratory Service Market: Figure 3 Drivers, Restraints, Opportunities, and Challenges
Figure 4 Global Clinical laboratory Service Market: By Product,
Figure 5 Global Clinical laboratory Service Market: By Application,
Figure 6 Global Clinical laboratory Service Market: By Region
Figure 7 North America Clinical laboratory Service Market: Market Snapshot
Figure 8 Europe Clinical laboratory Service Market: Market Snapshot
Figure 9 Asia-Pacific Clinical laboratory Service Market: Market Snapshot
Figure 10 LAMEA Clinical laboratory Service Market: Market Snapshot
Figure 11 Pfizer Inc. Financial Snapshot
Figure 12 Purdue Pharma Financial Snapshot
Figure 13 Boehringer Ingelheim Financial Snapshot
Figure 14 Janssen Pharmaceuticals, Inc. Financial Snapshot
Figure 15 Actavis Plc. Financial Snapshot
Figure 16 Sanofi Financial Snapshot
Figure 17 Sun Pharmaceutical Industries Ltd. Financial Snapshot
Figure 18 Mallinckrodt Pharmaceuticals Financial Snapshot
Figure 19 Endo Pharmaceuticals Inc. Financial Snapshot
Figure 20 Egalet. Financial Snapshot
Actavis Plc.
Acura Pharmaceuticals Inc.
Allergan
Amneal Pharmaceuticals Inc.
Boehringer Ingelheim
Cipher Pharmaceutical Inc.
Collegium Pharmaceutical, Inc.
Daiichi Sankyo Inc.
Egalet.
Endo Pharmaceuticals Inc.
Grunenthal GmbH
Heat Map Analysis of Private Companies
Insys Therapeutics
Janssen Pharmaceuticals, Inc.
Johnson & Johnson
Lupin Ltd.
Mallinckrodt Pharmaceuticals
Pfizer Inc.
Purdue Pharma
Sanofi
Sun Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd.
Titan Pharmaceuticals
Vertice Pharma LLC
West-Ward Pharmaceuticals Corporation